Traditional tumor markers, including carcinoembryonic antigen (CEA), squamous cell carcinoma antigen (SCC), and cytokeratin 19 fragment (CYFRA21-1), have low sensitivity and specificity. This evidence concerns the gene CEACAM5 and neoplasm.